Sicart Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-101,310
| Closed | -$11.4M | – | 73 |
|
|
2025
Q1 | $11.4M | Sell |
101,310
-4,620
| -4% | -$518K | 3.93% | 4 |
|
|
2024
Q4 | $9.78M | Sell |
105,930
-4,200
| -4% | -$388K | 3.5% | 6 |
|
|
2024
Q3 | $9.23M | Hold |
110,130
| – | – | 3.24% | 6 |
|
|
2024
Q2 | $7.56M | Sell |
110,130
-1,840
| -2% | -$126K | 2.9% | 12 |
|
|
2024
Q1 | $8.2M | Sell |
111,970
-1,690
| -1% | -$124K | 3% | 12 |
|
|
2023
Q4 | $9.21M | Sell |
113,660
-1,505
| -1% | -$122K | 3.52% | 8 |
|
|
2023
Q3 | $8.63M | Sell |
115,165
-175
| -0.2% | -$13.1K | 3.38% | 10 |
|
|
2023
Q2 | $8.89M | Sell |
115,340
-6,305
| -5% | -$486K | 3.45% | 7 |
|
|
2023
Q1 | $10.1M | Sell |
121,645
-21,850
| -15% | -$1.81M | 3.92% | 5 |
|
|
2022
Q4 | $12.3M | Sell |
143,495
-1,855
| -1% | -$159K | 4.34% | 5 |
|
|
2022
Q3 | $8.97M | Sell |
145,350
-24,550
| -14% | -$1.51M | 3.18% | 10 |
|
|
2022
Q2 | $10.5M | Sell |
169,900
-785
| -0.5% | -$48.5K | 3.27% | 9 |
|
|
2022
Q1 | $10.1M | Sell |
170,685
-15,455
| -8% | -$919K | 2.63% | 12 |
|
|
2021
Q4 | $13.7M | Sell |
186,140
-380
| -0.2% | -$27.9K | 3.56% | 10 |
|
|
2021
Q3 | $13M | Sell |
186,520
-6,920
| -4% | -$483K | 3.55% | 7 |
|
|
2021
Q2 | $13.3M | Sell |
193,440
-1,360
| -0.7% | -$93.6K | 3.17% | 11 |
|
|
2021
Q1 | $12.6M | Buy |
194,800
+2,900
| +2% | +$187K | 3.33% | 11 |
|
|
2020
Q4 | $11.2M | Buy |
191,900
+131,410
| +217% | +$7.66M | 2.76% | 13 |
|
|
2020
Q3 | $3.82M | Buy |
+60,490
| New | +$3.82M | 1.14% | 28 |
|